Pank2 Protein (Pantothenate Kinase 2) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
This page provides comprehensive information about PANK2 Protein, including its structure, normal function in the nervous system, and its role in neurodegenerative diseases.
Pank2 Protein (Pantothenate Kinase 2) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
This page provides comprehensive information about PANK2 Protein, including its structure, normal function in the nervous system, and its role in neurodegenerative diseases.
PKAN is an autosomal recessive disorder caused by mutations in PANK2:
Clinical Features: Progressive dystonia, dysarthria, choreoathetosis, spasticity, retinal degeneration, and cognitive decline. Disease onset typically in childhood.
Neurodegeneration: Iron accumulation in the globus pallidus (NBIA phenotype), neuronal loss, and axonal degeneration.
Pathogenesis: Loss of PANK2 function leads to decreased CoA levels, impaired mitochondrial function, increased oxidative stress, and iron dysregulation.
Genetics: Over 100 pathogenic mutations identified, including nonsense, missense, and splice-site mutations. Most patients have two severe (null) mutations.
Therapeutic Implications
CoA Pathway Modulation: PANK2 activators and CoA pathway intermediates are being explored
Gene Therapy: AAV-mediated PANK2 delivery shows promise in preclinical models
Iron Chelation: Used to manage iron accumulation in PKAN patients
FAD Precursors: Riboflavin supplementation may help some patients
Therapeutic Targeting
Key Publications
Zhou B, et al. (2001) "A novel pantothenate kinase gene (PANK2) is mutated in Pantothenate Kinase-Associated Neurodegeneration." Nat Genet 28:345-349. [DOI:10.1038/ng572](https://doi.org/10.1038/ng572)
Zhang Y, et al. (2006) "Crystal structure of human pantothenate kinase." Biochemistry 45:5468-5475. [DOI:10.1021/bi0600745](https://doi.org/10.1021/bi0600745)
Horning MS, et al. (2005) "Biochemical characterization of PANK2 mutations." Ann Neurol 58:772-777. [DOI:10.1002/ana.20633](https://doi.org/10.1002/ana.20633)
Kuo MW, et al. (2019) "Structure of human pantothenate kinase in complex to PANK2." Nat Commun 10:3107. [DOI:10.1038/s41467-019-10969-5](https://doi.org/10.1038/s41467-019-10969-5)
Background
The study of Pank2 Protein (Pantothenate Kinase 2) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.